SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Haselden Stuart

(Last) (First) (Middle)
C/O LULULEMON ATHLETICA INC.
1818 CORNWALL AVE

(Street)
VANCOUVER A1 V6J1C7

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
lululemon athletica inc. [ LULU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/29/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/29/2019 M 3,935 A $64.83 24,685 D
Common Stock 03/29/2019 M 4,742 A $53.79 29,427 D
Common Stock 03/29/2019 M 22,570 A $48.3 51,997 D
Common Stock 03/29/2019 M 1,500 A $68.69 53,497 D
Common Stock 03/29/2019 M 3,817 A $51.87 57,314 D
Common Stock 03/29/2019 M 2,797 A $85.96 60,111 D
Common Stock 03/29/2019 S 39,361 D $164.57(1) 20,750 D
Common Stock 03/29/2019 S 9,958 D $164.8(2) 10,792 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $64.83 03/29/2019 M 3,935 (3) 03/30/2022 Common Stock 3,935 $0 1,311 D
Stock Option (Right to Buy) $53.79 03/29/2019 M 4,742 (4) 09/14/2022 Common Stock 4,742 $0 1,581 D
Stock Option (Right to Buy) $48.3 03/29/2019 M 22,570 (5) 10/26/2022 Common Stock 22,570 $0 7,523 D
Stock Option (Right to Buy) $68.69 03/29/2019 M 1,500 (6) 04/01/2023 Common Stock 1,500 $0 9,888 D
Stock Option (Right to Buy) $51.87 03/29/2019 M 3,817 (7) 03/31/2024 Common Stock 3,817 $0 11,451 D
Stock Option (Right to Buy) $85.96 03/29/2019 M 2,797 (8) 03/28/2025 Common Stock 2,797 $0 8,389 D
Explanation of Responses:
1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.31 to $165.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges stated in footnotes (1) and (2) to this Form 4.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.67 to $165.10, inclusive.
3. These options vested as to 25% on each of March 30, 2016 , March 30, 2017, March 30, 2018, and March 30, 2019.
4. These options vested as to 25% on each of September 14, 2016, September 14, 2017, and September 14, 2018. An additional 25% will vest on September 14, 2019, subject to the reporting person's continued employment or association with the issuer through each such date.
5. These options vested as to 25% on each of October 26, 2016, October 26, 2017, and October 26, 2018. An additional 25% will vest on October 26, 2019, subject to the reporting person's continued employment or association with the issuer through each such date.
6. These options vested as to 25% on each of April 1, 2017, April 1, 2018, and April 1, 2019. An additional 25% will vest on April 1, 2020, subject to the reporting person's continued employment or association with the issuer through each such date.
7. These options vested as to 25% on each of March 31, 2018 and March 31, 2019. An additional 25% will vest on each of March 31, 2020 and March 31, 2021, subject to the reporting person's continued employment or association with the issuer through each such date.
8. These options vested as to 25% on March 28, 2019. An additional 25% will vest on each of March 28, 2020, March 28, 2021, and March 28, 2022, subject to the reporting person's continued employment or association with the issuer through each such date.
/s/ Stuart Haselden by Erin Nicholas, Attorney-in-Fact 04/02/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.